Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...
Norovirus, the infamous "winter vomiting disease," is surging again across the United States. Norovirus is a highly contagious stomach bug that causes sudden, often violent bouts of diarrhea and ...
Norovirus care results in about $28M in yearly costs for Veterans Health Administration, study finds
Norovirus treatment exerts a significant burden on Veterans Health Administration (VHA) spending, totalling $28 million in costs when extrapolated annually. That is according to an October study ...
The highly contagious norovirus – popularly known as "stomach flu" or the "winter vomiting bug" – is now surging through the U.S. The number of outbreaks is up significantly over previous years, ...
Five people were taken to the hospital amid a suspected norovirus outbreak at a Wayland, Massachusetts, assisted living ...
Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...
Health chiefs are urging vigilance as confirmed cases have more than doubled compared to last year, with alcohol-based hand ...
As of Tuesday afternoon, five people had been transported from the facility to local hospitals for treatment of their ...
Wayland first responders have transported five people so far from the facility for treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results